Business ❯ Pharmaceutical Industry

Acquisitions

Biotechnology Johnson & Johnson Foreign Investment Sanofi Metsera Research and Development Financial Outlook Drug Development J.P. Morgan Healthcare Conference Vaccine Development Vaccine Companies Bristol Myers Squibb Drug Pricing Eli Lilly Intra-Cellular Therapies

Lilly Agrees to Buy Three Vaccine Developers for Up to $3.8 Billion

The purchases mark a strategic shift into vaccine-led prevention that Lilly says will move forward only after routine regulatory clearances.

Novartis Strikes $2 Billion Deal for Mutant-Selective PI3Kα Cancer Drug SNV4818

Takeda’s AI-Assisted Psoriasis Pill Succeeds in Phase 3, Outperforms Otezla

Ianalumab Plus Eltrombopag Extends Disease Control in Phase 3 ITP Study Published in NEJM

FDA Approves J&J’s Caplyta for Major Depressive Disorder

Sanofi’s Efdoralprin Alfa Shows Superior Biomarker Response to Plasma Therapy in Phase 2 AATD Trial